Comparative study of high-dose Xuezhikang and low-dose Xuezhikang plus ezetimibe on pro- and anti-inflammatory markers

Author: Liu Jun   Luo Song-Hui   Qing Ping   Di Long-Hui   You Xiang-Dong   Han Hong-Yan   Jia Yan-Jun   Li Xiao-Lin   Wen Dan   Li Jian-Jun  

Publisher: Future Medicine

ISSN: 1758-4299

Source: Clinical Lipidology, Vol.8, Iss.1, 2013-02, pp. : 151-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract